Literature DB >> 2047890

Pathogenesis of sclerosing cholangitis: the role of nonimmune factors.

S Sherlock1.   

Abstract

The diagnosis of primary sclerosing cholangitis is made on cholangiographic appearances supported by liver histologic findings. Clinical features may be compatible but are not diagnostic and there is no specific diagnostic test. Immunologic mechanisms have been proposed as pathogenetic, but the evidence is far from conclusive. Similar cholangiographic and histologic changes are found in other diseases of known etiology, including infections with intestinal bacterial organisms and with cryptosporidiosis. Primary sclerosing cholangitis has a strong association with ulcerative colitis and possible mechanisms are discussed. Gut-derived toxic bacterial products may be implicated in the biliary damage. Vascular damage to the hepatic arterial tree by cytotoxic drugs, or after hepatic transplantation, also may produce the picture of sclerosing cholangitis. If the syndrome of sclerosing cholangitis can have so many possible causes, it seems likely that the "primary" type eventually may be found to have a known etiology (possibly infectious). At that point, it will no longer be considered primary.

Entities:  

Mesh:

Year:  1991        PMID: 2047890     DOI: 10.1055/s-2008-1040416

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  4 in total

1.  Experimental colitis in rats induces low-grade endotoxinemia without hepatobiliary abnormalities.

Authors:  H S Brand; M A Maas; A Bosma; R J Van Ketel; P Speelman; R A Chamuleau
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

Review 2.  Secondary sclerosing cholangitis.

Authors:  Petra Ruemmele; Ferdinand Hofstaedter; Cornelia M Gelbmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

3.  Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis.

Authors:  T Orth; R Kellner; O Diekmann; J Faust; K H Meyer zum Büschenfelde; W J Mayet
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

4.  Prophylaxis of post-ERC infectious complications in patients with biliary obstruction by adding antimicrobial agents into ERC contrast media- a single center retrospective study.

Authors:  Hella Wobser; Agnetha Gunesch; Frank Klebl
Journal:  BMC Gastroenterol       Date:  2017-01-13       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.